INVO Fertility Sets 1-for-4 Reverse Stock Split Effective October 30 on Nasdaq

INVO Fertility, Inc. (IVF) will effect a 1-for-4 reverse split of its issued and outstanding and authorized common stock, effective at 12:01 a.m. Eastern Time on October 30, 2026. The stock will begin trading on a post-split basis on the Nasdaq Capital Market that day under the same symbol, "IVF," with a new CUSIP number of 44984F872. Following the split, the company will have approximately 1.19 million shares outstanding, and authorized common stock will be proportionately reduced to 62.5 million shares. The move follows second-quarter 2026 net income of $0.9 million, reversing a $3.6 million net loss a year earlier; the latest quarter included an approximately $2.5 million gain tied to the Birmingham acquisition. Revenue rose 17% to $2,175,485 from $1,863,654. IVF has traded between $0.51 and $26.60 over the past 52 weeks and closed Tuesday at $0.61, up 8.09%.